Global Generic Medicine Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 124

As the global economy mends, the 2021 growth of Generic Medicine will have significant change from previous year. According to our (LP Information) latest study, the global Generic Medicine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Generic Medicine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Generic Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Generic Medicine market, reaching US$ million by the year 2028. As for the Europe Generic Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Generic Medicine players cover Teva, Novartis - Sandoz, Mylan, and Sun Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Generic Medicine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- Simple Generic Drugs

- Super Generic Drugs

- Biosimilars

- By Application:

- CNS

- Cardiovascular

- Respiratory

- Rheumatology

- Diabetes

- Oncology

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- CNS

- Cardiovascular

- Respiratory

- Rheumatology

- Diabetes

- Oncology

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Teva

- Novartis - Sandoz

- Mylan

- Sun Pharmaceutical

- Aspen

- Fresenius Kabi

- Pfizer (Hospira)

- Sanofi

- Aurobindo

- Lupin

- Dr. Reddy's

- Apotex

- Cipla

- ENDO (Par Pharmaceutical)

- Stada Arzneimittel

- Krka Group

- Nichi-Iko Pharmaceutical

- Valeant

- Zydus Cadila

- Hikma

Global Generic Medicine Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Medicine Market Size 2017-2028
2.1.2 Generic Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Generic Medicine Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.2.4 By Application:
2.2.5 CNS
2.2.6 Cardiovascular
2.2.7 Respiratory
2.2.8 Rheumatology
2.2.9 Diabetes
2.2.10 Oncology
2.3 Generic Medicine Market Size by Type
2.3.1 Generic Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Generic Medicine Market Size Market Share by Type (2017-2022)
2.4 Generic Medicine Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Respiratory
2.4.4 Rheumatology
2.4.5 Diabetes
2.4.6 Oncology
2.4.7 Others
2.5 Generic Medicine Market Size by Application
2.5.1 Generic Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Generic Medicine Market Size Market Share by Application (2017-2022)
3 Generic Medicine Market Size by Player
3.1 Generic Medicine Market Size Market Share by Players
3.1.1 Global Generic Medicine Revenue by Players (2020-2022)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2020-2022)
3.2 Global Generic Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Medicine by Regions
4.1 Generic Medicine Market Size by Regions (2017-2022)
4.2 Americas Generic Medicine Market Size Growth (2017-2022)
4.3 APAC Generic Medicine Market Size Growth (2017-2022)
4.4 Europe Generic Medicine Market Size Growth (2017-2022)
4.5 Middle East & Africa Generic Medicine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Generic Medicine Market Size by Country (2017-2022)
5.2 Americas Generic Medicine Market Size by Type (2017-2022)
5.3 Americas Generic Medicine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Medicine Market Size by Region (2017-2022)
6.2 APAC Generic Medicine Market Size by Type (2017-2022)
6.3 APAC Generic Medicine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Medicine by Country (2017-2022)
7.2 Europe Generic Medicine Market Size by Type (2017-2022)
7.3 Europe Generic Medicine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Medicine by Region (2017-2022)
8.2 Middle East & Africa Generic Medicine Market Size by Type (2017-2022)
8.3 Middle East & Africa Generic Medicine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Medicine Market Forecast
10.1 Global Generic Medicine Forecast by Regions (2023-2028)
10.1.1 Global Generic Medicine Forecast by Regions (2023-2028)
10.1.2 Americas Generic Medicine Forecast
10.1.3 APAC Generic Medicine Forecast
10.1.4 Europe Generic Medicine Forecast
10.1.5 Middle East & Africa Generic Medicine Forecast
10.2 Americas Generic Medicine Forecast by Country (2023-2028)
10.2.1 United States Generic Medicine Market Forecast
10.2.2 Canada Generic Medicine Market Forecast
10.2.3 Mexico Generic Medicine Market Forecast
10.2.4 Brazil Generic Medicine Market Forecast
10.3 APAC Generic Medicine Forecast by Region (2023-2028)
10.3.1 China Generic Medicine Market Forecast
10.3.2 Japan Generic Medicine Market Forecast
10.3.3 Korea Generic Medicine Market Forecast
10.3.4 Southeast Asia Generic Medicine Market Forecast
10.3.5 India Generic Medicine Market Forecast
10.3.6 Australia Generic Medicine Market Forecast
10.4 Europe Generic Medicine Forecast by Country (2023-2028)
10.4.1 Germany Generic Medicine Market Forecast
10.4.2 France Generic Medicine Market Forecast
10.4.3 UK Generic Medicine Market Forecast
10.4.4 Italy Generic Medicine Market Forecast
10.4.5 Russia Generic Medicine Market Forecast
10.5 Middle East & Africa Generic Medicine Forecast by Region (2023-2028)
10.5.1 Egypt Generic Medicine Market Forecast
10.5.2 South Africa Generic Medicine Market Forecast
10.5.3 Israel Generic Medicine Market Forecast
10.5.4 Turkey Generic Medicine Market Forecast
10.5.5 GCC Countries Generic Medicine Market Forecast
10.6 Global Generic Medicine Forecast by Type (2023-2028)
10.7 Global Generic Medicine Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Medicine Product Offered
11.1.3 Teva Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Information
11.2.2 Novartis - Sandoz Generic Medicine Product Offered
11.2.3 Novartis - Sandoz Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis - Sandoz Main Business Overview
11.2.5 Novartis - Sandoz Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Generic Medicine Product Offered
11.3.3 Mylan Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Medicine Product Offered
11.4.3 Sun Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Medicine Product Offered
11.5.3 Aspen Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Medicine Product Offered
11.6.3 Fresenius Kabi Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Medicine Product Offered
11.7.3 Pfizer (Hospira) Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Medicine Product Offered
11.8.3 Sanofi Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Medicine Product Offered
11.9.3 Aurobindo Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Medicine Product Offered
11.10.3 Lupin Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Medicine Product Offered
11.11.3 Dr. Reddy's Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Medicine Product Offered
11.12.3 Apotex Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Medicine Product Offered
11.13.3 Cipla Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Medicine Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Medicine Product Offered
11.15.3 Stada Arzneimittel Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Medicine Product Offered
11.16.3 Krka Group Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Medicine Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Medicine Product Offered
11.18.3 Valeant Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Medicine Product Offered
11.19.3 Zydus Cadila Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Medicine Product Offered
11.20.3 Hikma Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Generic Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Simple Generic Drugs
Table 3. Major Players of Super Generic Drugs
Table 4. Major Players of Biosimilars
Table 5. Major Players of By Application:
Table 6. Major Players of CNS
Table 7. Major Players of Cardiovascular
Table 8. Major Players of Respiratory
Table 9. Major Players of Rheumatology
Table 10. Major Players of Diabetes
Table 11. Major Players of Oncology
Table 12. Generic Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Generic Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 14. Global Generic Medicine Market Size Market Share by Type (2017-2022)
Table 15. Generic Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 16. Global Generic Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 17. Global Generic Medicine Market Size Market Share by Application (2017-2022)
Table 18. Global Generic Medicine Revenue by Players (2020-2022) & ($ Millions)
Table 19. Global Generic Medicine Revenue Market Share by Player (2020-2022)
Table 20. Generic Medicine Key Players Head office and Products Offered
Table 21. Generic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Generic Medicine Market Size by Regions 2017-2022 & ($ Millions)
Table 25. Global Generic Medicine Market Size Market Share by Regions (2017-2022)
Table 26. Americas Generic Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 27. Americas Generic Medicine Market Size Market Share by Country (2017-2022)
Table 28. Americas Generic Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 29. Americas Generic Medicine Market Size Market Share by Type (2017-2022)
Table 30. Americas Generic Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 31. Americas Generic Medicine Market Size Market Share by Application (2017-2022)
Table 32. APAC Generic Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 33. APAC Generic Medicine Market Size Market Share by Region (2017-2022)
Table 34. APAC Generic Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 35. APAC Generic Medicine Market Size Market Share by Type (2017-2022)
Table 36. APAC Generic Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 37. APAC Generic Medicine Market Size Market Share by Application (2017-2022)
Table 38. Europe Generic Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 39. Europe Generic Medicine Market Size Market Share by Country (2017-2022)
Table 40. Europe Generic Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 41. Europe Generic Medicine Market Size Market Share by Type (2017-2022)
Table 42. Europe Generic Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 43. Europe Generic Medicine Market Size Market Share by Application (2017-2022)
Table 44. Middle East & Africa Generic Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Generic Medicine Market Size Market Share by Region (2017-2022)
Table 46. Middle East & Africa Generic Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Generic Medicine Market Size Market Share by Type (2017-2022)
Table 48. Middle East & Africa Generic Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 49. Middle East & Africa Generic Medicine Market Size Market Share by Application (2017-2022)
Table 50. Key Market Drivers & Growth Opportunities of Generic Medicine
Table 51. Key Market Challenges & Risks of Generic Medicine
Table 52. Key Industry Trends of Generic Medicine
Table 53. Global Generic Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 54. Global Generic Medicine Market Size Market Share Forecast by Regions (2023-2028)
Table 55. Global Generic Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 56. Global Generic Medicine Market Size Market Share Forecast by Type (2023-2028)
Table 57. Global Generic Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 58. Global Generic Medicine Market Size Market Share Forecast by Application (2023-2028)
Table 59. Teva Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 60. Teva Generic Medicine Product Offered
Table 61. Teva Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Teva Main Business
Table 63. Teva Latest Developments
Table 64. Novartis - Sandoz Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 65. Novartis - Sandoz Generic Medicine Product Offered
Table 66. Novartis - Sandoz Main Business
Table 67. Novartis - Sandoz Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Novartis - Sandoz Latest Developments
Table 69. Mylan Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 70. Mylan Generic Medicine Product Offered
Table 71. Mylan Main Business
Table 72. Mylan Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Mylan Latest Developments
Table 74. Sun Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 75. Sun Pharmaceutical Generic Medicine Product Offered
Table 76. Sun Pharmaceutical Main Business
Table 77. Sun Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Sun Pharmaceutical Latest Developments
Table 79. Aspen Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 80. Aspen Generic Medicine Product Offered
Table 81. Aspen Main Business
Table 82. Aspen Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Aspen Latest Developments
Table 84. Fresenius Kabi Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 85. Fresenius Kabi Generic Medicine Product Offered
Table 86. Fresenius Kabi Main Business
Table 87. Fresenius Kabi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Fresenius Kabi Latest Developments
Table 89. Pfizer (Hospira) Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 90. Pfizer (Hospira) Generic Medicine Product Offered
Table 91. Pfizer (Hospira) Main Business
Table 92. Pfizer (Hospira) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Pfizer (Hospira) Latest Developments
Table 94. Sanofi Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 95. Sanofi Generic Medicine Product Offered
Table 96. Sanofi Main Business
Table 97. Sanofi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Sanofi Latest Developments
Table 99. Aurobindo Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 100. Aurobindo Generic Medicine Product Offered
Table 101. Aurobindo Main Business
Table 102. Aurobindo Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Aurobindo Latest Developments
Table 104. Lupin Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 105. Lupin Generic Medicine Product Offered
Table 106. Lupin Main Business
Table 107. Lupin Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Lupin Latest Developments
Table 109. Dr. Reddy's Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 110. Dr. Reddy's Generic Medicine Product Offered
Table 111. Dr. Reddy's Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Dr. Reddy's Main Business
Table 113. Dr. Reddy's Latest Developments
Table 114. Apotex Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 115. Apotex Generic Medicine Product Offered
Table 116. Apotex Main Business
Table 117. Apotex Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Apotex Latest Developments
Table 119. Cipla Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 120. Cipla Generic Medicine Product Offered
Table 121. Cipla Main Business
Table 122. Cipla Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Cipla Latest Developments
Table 124. ENDO (Par Pharmaceutical) Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 125. ENDO (Par Pharmaceutical) Generic Medicine Product Offered
Table 126. ENDO (Par Pharmaceutical) Main Business
Table 127. ENDO (Par Pharmaceutical) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. ENDO (Par Pharmaceutical) Latest Developments
Table 129. Stada Arzneimittel Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 130. Stada Arzneimittel Generic Medicine Product Offered
Table 131. Stada Arzneimittel Main Business
Table 132. Stada Arzneimittel Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Stada Arzneimittel Latest Developments
Table 134. Krka Group Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 135. Krka Group Generic Medicine Product Offered
Table 136. Krka Group Main Business
Table 137. Krka Group Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Krka Group Latest Developments
Table 139. Nichi-Iko Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 140. Nichi-Iko Pharmaceutical Generic Medicine Product Offered
Table 141. Nichi-Iko Pharmaceutical Main Business
Table 142. Nichi-Iko Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Nichi-Iko Pharmaceutical Latest Developments
Table 144. Valeant Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 145. Valeant Generic Medicine Product Offered
Table 146. Valeant Main Business
Table 147. Valeant Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Valeant Latest Developments
Table 149. Zydus Cadila Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 150. Zydus Cadila Generic Medicine Product Offered
Table 151. Zydus Cadila Main Business
Table 152. Zydus Cadila Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. Zydus Cadila Latest Developments
Table 154. Hikma Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 155. Hikma Generic Medicine Product Offered
Table 156. Hikma Main Business
Table 157. Hikma Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. Hikma Latest Developments
List of Figures
Figure 1. Generic Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Medicine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Generic Medicine Market Size Market Share by Type in 2021
Figure 7. Generic Medicine in CNS
Figure 8. Global Generic Medicine Market: CNS (2017-2022) & ($ Millions)
Figure 9. Generic Medicine in Cardiovascular
Figure 10. Global Generic Medicine Market: Cardiovascular (2017-2022) & ($ Millions)
Figure 11. Generic Medicine in Respiratory
Figure 12. Global Generic Medicine Market: Respiratory (2017-2022) & ($ Millions)
Figure 13. Generic Medicine in Rheumatology
Figure 14. Global Generic Medicine Market: Rheumatology (2017-2022) & ($ Millions)
Figure 15. Generic Medicine in Diabetes
Figure 16. Global Generic Medicine Market: Diabetes (2017-2022) & ($ Millions)
Figure 17. Generic Medicine in Oncology
Figure 18. Global Generic Medicine Market: Oncology (2017-2022) & ($ Millions)
Figure 19. Generic Medicine in Others
Figure 20. Global Generic Medicine Market: Others (2017-2022) & ($ Millions)
Figure 21. Global Generic Medicine Market Size Market Share by Application in 2021
Figure 22. Global Generic Medicine Revenue Market Share by Player in 2021
Figure 23. Global Generic Medicine Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Generic Medicine Market Size 2017-2022 ($ Millions)
Figure 25. APAC Generic Medicine Market Size 2017-2022 ($ Millions)
Figure 26. Europe Generic Medicine Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Generic Medicine Market Size 2017-2022 ($ Millions)
Figure 28. Americas Generic Medicine Value Market Share by Country in 2021
Figure 29. Americas Generic Medicine Consumption Market Share by Type in 2021
Figure 30. Americas Generic Medicine Market Size Market Share by Application in 2021
Figure 31. United States Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Generic Medicine Market Size Market Share by Region in 2021
Figure 36. APAC Generic Medicine Market Size Market Share by Application in 2021
Figure 37. China Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Generic Medicine Market Size Market Share by Country in 2021
Figure 44. Europe Generic Medicine Market Size Market Share by Type in 2021
Figure 45. Europe Generic Medicine Market Size Market Share by Application in 2021
Figure 46. Germany Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Generic Medicine Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Generic Medicine Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Generic Medicine Market Size Market Share by Application in 2021
Figure 54. Egypt Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Generic Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 60. APAC Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 61. Europe Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 63. United States Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 64. Canada Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 67. China Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 68. Japan Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 69. Korea Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 71. India Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 72. Australia Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 73. Germany Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 74. France Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 75. UK Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 76. Italy Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 77. Russia Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 78. Spain Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 81. Israel Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Generic Medicine Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Generic Medicine Market Size 2023-2028 ($ Millions)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs